|
Volumn 19, Issue 6, 2009, Pages 572-573
|
Swine-origin influenza virus A(H1N1)v: Lessons learnt from the early phase of the epidemic
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIVIRUS AGENT;
INFLUENZA VACCINE;
OSELTAMIVIR;
ZANAMIVIR;
AVIAN INFLUENZA;
CHEMOPROPHYLAXIS;
COST EFFECTIVENESS ANALYSIS;
DISEASE DURATION;
DISEASE SEVERITY;
EPIDEMIC;
FATALITY;
GENE MUTATION;
GUILLAIN BARRE SYNDROME;
HEALTH CARE SYSTEM;
HUMAN;
IMMUNE RESPONSE;
IMMUNITY;
INFECTION CONTROL;
INFLUENZA;
INFLUENZA VACCINATION;
INFLUENZA VIRUS A H1N1;
MASS IMMUNIZATION;
NOTE;
PANDEMIC;
PNEUMONIA;
PRIORITY JOURNAL;
PUBLIC HEALTH;
PUBLIC HEALTH SERVICE;
RESPIRATORY DISTRESS SYNDROME;
RISK REDUCTION;
SEASONAL VARIATION;
SEVERE ACUTE RESPIRATORY SYNDROME;
SWINE INFLUENZA VIRUS;
UNITED STATES;
VIRUS IDENTIFICATION;
VIRUS TRANSMISSION;
WORLD HEALTH ORGANIZATION;
AGE DISTRIBUTION;
ANTIVIRAL AGENTS;
HUMANS;
INFLUENZA A VIRUS, H1N1 SUBTYPE;
INFLUENZA, HUMAN;
PANDEMICS;
VACCINATION;
|
EID: 71449109359
PISSN: 11011262
EISSN: 1464360X
Source Type: Journal
DOI: 10.1093/eurpub/ckp156 Document Type: Note |
Times cited : (1)
|
References (10)
|